Global 
Australia 
België 
Deutschland 
España 
France 
Ireland 
Italia 
Luxembourg 
Nederland 
Österreich 
Portugal 
Россия 
Schweiz 
United Kingdom 
Back To The Future #2 – Advancing the plot with established therapies
ECCO 2026: Symposium on 19.02.2026 in Stockholm
We are pleased to invite you to the Dr. Falk Pharma satellite symposium on Thursday, 19 February 2026, during the 21st Congress of ECCO.
Established therapies continue to play a key role in the management of IBD and related diseases. This symposium highlights practical, evidence-based approaches to optimize their use, particularly 2nd-generation corticosteroids, to improve patient outcomes.
Our program features discussions led by renowned experts, including:
- Oral and rectal treatment: The power of established IBD drugs
Prof. Geert D’Haens (Amsterdam UMC, the Netherlands) - Ulcerative proctitis and left-sided colitis: A to Z of treatment
Dr. Tommaso Parigi (IRCCS San Raffaele Hospital, Milan, Italy) - Recognizing the overlooked: Mild-to-moderate CD and the microscopic colitis you didn’t expect
Dr. Rupa Banerjee (AIG Hospitals, Hyderabad, India) - Performance with precision: Meet the 2nd-generation steroid for EoE
Prof. Luc Biedermann (University Hospital Zurich, Switzerland)
Join us in Room A11 for an engaging and interactive discussion as we advance the plot with established therapies.
We look forward to your participation and the opportunity to connect with you at ECCO 2026, as we advance the conversation on optimizing IBD treatment together. Our booth no. is 23!
